Get started
Author

Sabrina Orzetti

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
2021 · Nicoletta Luxi, Alexia Giovanazzi, et al. · Drug Safety · 143
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice
2022 · Sabrina Orzetti, Federica Tommasi, et al. · International Journal of Molecular Sciences · 30
PDF
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials
2023 · Fariba Ahmadizar, Nicoletta Luxi, et al. · Drug Safety · 15
PDF
Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports
2023 · Sabrina Orzetti, Paolo Baldo · International Journal of Molecular Sciences · 13
PDF
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)
2024 · Alessandro Cafaro, Flavia Foca, et al. · Cancers · 12
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)
2024 · Alessandro Cafaro, Flavia Foca, et al. · Frontiers in Oncology · 9
PDF
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance
2024 · Anna Parzianello, Giulia Fornasier, et al. · Pharmaceuticals · 6
PDF
Effectiveness of azacytidine for poly ADP-ribose polymerase inhibitor-induced myelodysplastic syndrome in ovarian cancer patient: a twofold triumph
2026 · Stefano Fucina, Riccardo Vida, et al. · Journal of Chemotherapy · 1
Works count: 8
Citation count: 229
H-index: 6
I10-index: 5
Year
Topic
Type